Competitive Density
Data updated: May 20, 2026
Active trials by therapeutic area and indication
Density Legend (based on active Phase 3 trials & sponsor count)
Hot (crowded)
Warm (competitive)
Cool (moderate)
Cold (sparse)
Oncology
21755 active trialsSolid Tumor (Advanced)
Ph3: 375 • Ph2: 1801 • 759 sponsors
Breast Cancer
Ph3: 323 • Ph2: 896 • 193 sponsors
NSCLC
Ph3: 279 • Ph2: 888 • 316 sponsors
Colorectal Cancer
Ph3: 185 • Ph2: 737 • 221 sponsors
Non-Hodgkin Lymphoma
Ph3: 179 • Ph2: 1031 • 227 sponsors
Prostate Cancer
Ph3: 156 • Ph2: 542 • 146 sponsors
Multiple Myeloma
Ph3: 113 • Ph2: 395 • 88 sponsors
Hepatocellular Carcinoma
Ph3: 93 • Ph2: 392 • 119 sponsors
Gastric Cancer
Ph3: 85 • Ph2: 313 • 119 sponsors
Bladder Cancer
Ph3: 84 • Ph2: 258 • 107 sponsors
Ovarian Cancer
Ph3: 82 • Ph2: 300 • 159 sponsors
AML
Ph3: 76 • Ph2: 383 • 111 sponsors
Esophageal Cancer
Ph3: 76 • Ph2: 274 • 81 sponsors
Lung Cancer (General)
Ph3: 75 • Ph2: 347 • 105 sponsors
Pancreatic Cancer
Ph3: 70 • Ph2: 410 • 191 sponsors
Melanoma
Ph3: 61 • Ph2: 312 • 141 sponsors
Hematologic Malignancies
Ph3: 61 • Ph2: 332 • 83 sponsors
Head and Neck Cancer
Ph3: 55 • Ph2: 332 • 147 sponsors
Cervical Cancer
Ph3: 46 • Ph2: 165 • 74 sponsors
ALL
Ph3: 46 • Ph2: 248 • 53 sponsors
Triple Negative Breast Cancer
Ph3: 42 • Ph2: 211 • 97 sponsors
SCLC
Ph3: 41 • Ph2: 176 • 80 sponsors
CLL
Ph3: 40 • Ph2: 147 • 45 sponsors
Squamous Cell Carcinoma
Ph3: 37 • Ph2: 227 • 49 sponsors
MDS
Ph3: 35 • Ph2: 242 • 77 sponsors
Renal Cell Carcinoma
Ph3: 34 • Ph2: 181 • 78 sponsors
Brain Tumor
Ph3: 34 • Ph2: 148 • 49 sponsors
Endometrial Cancer
Ph3: 32 • Ph2: 139 • 91 sponsors
Cholangiocarcinoma
Ph3: 32 • Ph2: 201 • 62 sponsors
Glioblastoma
Ph3: 30 • Ph2: 205 • 81 sponsors
Sarcoma
Ph3: 29 • Ph2: 279 • 67 sponsors
HER2+ Breast Cancer
Ph3: 24 • Ph2: 70 • 19 sponsors
Neuroendocrine Tumors
Ph3: 21 • Ph2: 82 • 26 sponsors
Thyroid Cancer
Ph3: 18 • Ph2: 61 • 19 sponsors
HER2- Breast Cancer
Ph3: 16 • Ph2: 82 • 28 sponsors
Myelofibrosis
Ph3: 15 • Ph2: 62 • 30 sponsors
Hodgkin Lymphoma
Ph3: 13 • Ph2: 115 • 15 sponsors
CML
Ph3: 9 • Ph2: 80 • 15 sponsors
Merkel Cell Carcinoma
Ph3: 4 • Ph2: 36 • 16 sponsors
Mesothelioma
Ph3: 1 • Ph2: 54 • 35 sponsors
CNS
2149 active trialsAlzheimer's Disease
Ph3: 86 • Ph2: 202 • 92 sponsors
Major Depression
Ph3: 79 • Ph2: 184 • 49 sponsors
Multiple Sclerosis
Ph3: 53 • Ph2: 72 • 35 sponsors
Migraine
Ph3: 37 • Ph2: 19 • 13 sponsors
Schizophrenia
Ph3: 34 • Ph2: 41 • 32 sponsors
Opioid Use Disorder
Ph3: 29 • Ph2: 51 • 10 sponsors
Epilepsy
Ph3: 27 • Ph2: 29 • 22 sponsors
Parkinson's Disease
Ph3: 23 • Ph2: 103 • 68 sponsors
Anxiety
Ph3: 21 • Ph2: 49 • 18 sponsors
Neuropathy
Ph3: 20 • Ph2: 42 • 17 sponsors
ALS
Ph3: 18 • Ph2: 54 • 45 sponsors
Bipolar Disorder
Ph3: 17 • Ph2: 16 • 8 sponsors
Alcohol Use Disorder
Ph3: 16 • Ph2: 83 • 9 sponsors
Autism Spectrum Disorder
Ph3: 14 • Ph2: 52 • 12 sponsors
PTSD
Ph3: 13 • Ph2: 49 • 7 sponsors
ADHD
Ph3: 9 • Ph2: 12 • 3 sponsors
Huntington's Disease
Ph3: 5 • Ph2: 16 • 10 sponsors
OCD
Ph3: 2 • Ph2: 15 • 1 sponsors
Cardiovascular
1415 active trialsStroke
Ph3: 155 • Ph2: 141 • 54 sponsors
Hypertension
Ph3: 88 • Ph2: 106 • 82 sponsors
Heart Failure
Ph3: 71 • Ph2: 103 • 44 sponsors
Coronary Artery Disease
Ph3: 39 • Ph2: 35 • 27 sponsors
Atrial Fibrillation
Ph3: 36 • Ph2: 23 • 9 sponsors
Myocardial Infarction
Ph3: 27 • Ph2: 23 • 15 sponsors
Thrombosis
Ph3: 26 • Ph2: 7 • 5 sponsors
Hypertrophic Cardiomyopathy
Ph3: 9 • Ph2: 10 • 8 sponsors
Arrhythmia
Ph3: 7 • Ph2: 10 • 4 sponsors
Metabolic
1406 active trialsObesity
Ph3: 135 • Ph2: 192 • 92 sponsors
Type 2 Diabetes
Ph3: 75 • Ph2: 81 • 71 sponsors
Diabetes (General)
Ph3: 44 • Ph2: 69 • 34 sponsors
Dyslipidemia
Ph3: 35 • Ph2: 24 • 35 sponsors
Type 1 Diabetes
Ph3: 27 • Ph2: 67 • 25 sponsors
Diabetic Complications
Ph3: 24 • Ph2: 54 • 44 sponsors
NASH/NAFLD
Ph3: 22 • Ph2: 59 • 32 sponsors
Infectious Disease
1172 active trialsHIV
Ph3: 67 • Ph2: 122 • 17 sponsors
COVID-19
Ph3: 55 • Ph2: 97 • 43 sponsors
Tuberculosis
Ph3: 40 • Ph2: 43 • 12 sponsors
Sepsis
Ph3: 31 • Ph2: 41 • 8 sponsors
Influenza
Ph3: 22 • Ph2: 25 • 24 sponsors
Hepatitis B
Ph3: 16 • Ph2: 49 • 33 sponsors
RSV
Ph3: 14 • Ph2: 20 • 22 sponsors
Malaria
Ph3: 14 • Ph2: 21 • 7 sponsors
H. pylori
Ph3: 13 • Ph2: 9 • 2 sponsors
Fungal Infections
Ph3: 12 • Ph2: 15 • 11 sponsors
C. difficile
Ph3: 6 • Ph2: 11 • 5 sponsors
Bacterial Infections
Ph3: 5 • Ph2: 8 • 9 sponsors
Hepatitis C
Ph3: 2 • Ph2: 5 • 1 sponsors
Immunology
1087 active trialsPsoriasis
Ph3: 53 • Ph2: 35 • 54 sponsors
Atopic Dermatitis
Ph3: 49 • Ph2: 66 • 78 sponsors
Crohn's Disease
Ph3: 44 • Ph2: 54 • 27 sponsors
Lupus
Ph3: 39 • Ph2: 106 • 104 sponsors
Ulcerative Colitis
Ph3: 36 • Ph2: 72 • 40 sponsors
Psoriatic Arthritis
Ph3: 22 • Ph2: 14 • 19 sponsors
Rheumatoid Arthritis
Ph3: 20 • Ph2: 50 • 57 sponsors
Ankylosing Spondylitis
Ph3: 8 • Ph2: 8 • 9 sponsors
IBD
Ph3: 4 • Ph2: 12 • 7 sponsors
Pain
688 active trialsRespiratory
569 active trialsRare Disease
426 active trialsImmune Thrombocytopenia
Ph3: 35 • Ph2: 86 • 37 sponsors
Hemophilia
Ph3: 33 • Ph2: 20 • 23 sponsors
Sickle Cell Disease
Ph3: 22 • Ph2: 64 • 19 sponsors
Duchenne Muscular Dystrophy
Ph3: 10 • Ph2: 29 • 24 sponsors
Spinal Muscular Atrophy
Ph3: 10 • Ph2: 12 • 14 sponsors
Fabry Disease
Ph3: 9 • Ph2: 7 • 10 sponsors
CDKL5 Deficiency Disorder
Ph3: 2 • Ph2: 0 • 2 sponsors
Gaucher Disease
Ph3: 1 • Ph2: 6 • 4 sponsors
Mastocytosis
Ph3: 1 • Ph2: 5 • 4 sponsors
Musculoskeletal
312 active trialsOphthalmology
258 active trialsRenal
228 active trialsGastrointestinal
216 active trialsWomen's Health
183 active trialsDermatology
172 active trialsHepatology
114 active trialsUrology
103 active trialsSleep
74 active trialsEndocrine
42 active trialsHot = Crowded space, many late-stage competitors
Cold = Less competition, potential opportunity or difficult indication